Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sphenopalatine Ganglion Block for Postdural Puncture Headache
NCT02181205Withdrawn
- Sponsor
- Wake Forest University Health Sciences
- Start
- Nov 2014
- Primary completion
- Dec 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial in post-dural puncture headache (PDPH) comparing bupivacaine with placebo (2 arms). Primary endpoint: Verbal Pain Score at 1 hour. Planned start Nov 2014; status: withdrawn.
02
Drugs
bupivacaine
03
Conditions
post-dural puncture headache (PDPH)
Beyond the preview
Go deeper on NCT02181205.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02181205.